LEADER 03560nam 2200613 450 001 9910813600703321 005 20230725053328.0 035 $a(CKB)3710000000058267 035 $a(EBL)3115877 035 $a(SSID)ssj0001048615 035 $a(PQKBManifestationID)11599999 035 $a(PQKBTitleCode)TC0001048615 035 $a(PQKBWorkID)11015035 035 $a(PQKB)10867864 035 $a(MiAaPQ)EBC3115877 035 $a(Au-PeEL)EBL3115877 035 $a(CaPaEBR)ebr10781937 035 $a(OCoLC)922966377 035 $a(EXLCZ)993710000000058267 100 $a20131031d2011 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aAccess to medicines and vaccines in the South $ecoherence of rules and policies applied by the European Union Commission /$fStephen Kingah 210 1$aBrussels, Belgium :$cVUBPress,$d2011. 210 4$dİ2011 215 $a1 online resource (282 p.) 225 1 $aInstitute for European Studies - publication series ;$vNumber 20 300 $aDescription based upon print version of record. 311 $a90-5487-976-9 320 $aIncludes bibliographical references. 327 $aTable of contents -- Acknowledgement -- Preface -- Chapter 1: Introduction: using coherence to understand the problem -- Chapter 2: The international law and political economy of access to affordable medicines in the South -- Chapter 3: The coherence of EU primary and secondary rules and the goal of access to medicines in the South: substantive coherence -- Chapter 4: Institutional coherence for access to medicines and vaccines in the South: the case of the European Commission, the Parliament and the Council -- Chapter 5: Adjudicative coherence for access to affordable medicines and vaccines in the South: approaches of the court of justice (CJ) and the European Committee on social rightsChapter Six " Conclusions: A checklist for EU coherence for access and the way forward -- Epilogue -- Bibliography -- Official EC documents -- List of cases of the European court of justice -- List of WTO cases -- Other cases -- Interviews -- List of abbreviations. 330 8 $aHow can developing countries maximize some of the beneficial rules and policies provided to them by the EU and international organizations to reduce public health plight in terms of inadequate access to medicines and vaccines? By navigating some of the complex European and international rules and policies that have hitherto been put in place to ease access to affordable healthcare, the author identifies ways in which policy makers and legislators can optimally use extant rules to enhance healthcare provision. 410 0$aPublication series (Vrije Universiteit Brussel. Institute for European Studies) ;$vno. 20. 606 $aDrug accessibility$zDeveloping countries 606 $aPharmaceutical policy$zEuropean Union countries 606 $aMedical care, Cost of$zDeveloping countries 606 $aPublic health$zDeveloping countries 615 0$aDrug accessibility 615 0$aPharmaceutical policy 615 0$aMedical care, Cost of 615 0$aPublic health 676 $a362.1969792 700 $aKingah$b Stephen$01724690 712 02$aVrije Universiteit Brussel.$bInstitute for European Studies. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910813600703321 996 $aAccess to medicines and vaccines in the South$94126975 997 $aUNINA